(−)-Epigallocatechin Gallate but Not Chlorogenic Acid Upregulates Osteoprotegerin Synthesis Through Regulation of Bone Morphogenetic Protein-4 in Osteoblasts

Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm.2017.4491
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Amplification by (‑)‑epigallocatechin Gallate of Prostaglandin F2α‑stimulated Synthesis of Osteoprotegerin in Osteoblasts

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2017English

Amplification by (-)-Epigallocatechin Gallate and Chlorogenic Acid of TNF-α-stimulated Interleukin-6 Synthesis in Osteoblasts

International Journal of Molecular Medicine
MedicineGenetics
2015English

Mimosine Suppresses the PGF2α-induced Synthesis of Osteoprotegerin but Not Interleukin-6 in Osteoblasts

International Journal of Molecular Medicine
MedicineGenetics
2016English

Promoting Bone Morphogenetic Protein Signaling Through Negative Regulation of Inhibitory Smads

EMBO Journal
ImmunologyMolecular BiologyBiochemistryMicrobiology NeuroscienceMedicineGenetics
2001English

Retinoic Acid Repression of Bone Morphogenetic Protein 4 in Inner Ear Development

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2003English

WNT/Β-Catenin Signaling Activates Bone Morphogenetic Protein 2 Expression in Osteoblasts

Bone
EndocrinologyPhysiologyHistologyMetabolismDiabetes
2013English

Bone Morphogenetic Protein-2 Enhances WNT/Β-Catenin Signaling-Induced Osteoprotegerin Expression

Genes to Cells
MedicineGeneticsCell Biology
2009English

The Extracellular Regulation of Bone Morphogenetic Protein Signaling

Development (Cambridge)
Developmental BiologyMolecular Biology
2009English

The Mouse Bone Morphogenetic Protein-4 Gene

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy